Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) Short Interest Update

Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) was the target of a significant drop in short interest during the month of June. As of June 30th, there was short interest totaling 21,160 shares, a drop of 35.1% from the June 15th total of 32,585 shares. Based on an average daily volume of 2 shares, the short-interest ratio is currently 10,580.0 days.

Towa Pharmaceutical Stock Performance

Shares of Towa Pharmaceutical stock opened at $26.00 on Friday. Towa Pharmaceutical has a 1-year low of $25.71 and a 1-year high of $26.00. The company’s fifty day simple moving average is $25.44 and its 200-day simple moving average is $25.37.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley upgraded Towa Pharmaceutical to an “overweight” rating in a research note on Friday, June 12th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy”.

About Towa Pharmaceutical

Towa Pharmaceutical Co, Ltd. (OTCMKTS:TWAPF) is a Japan-based healthcare company primarily engaged in the research, development, manufacturing and sale of pharmaceutical products. The company’s product portfolio spans active pharmaceutical ingredients (APIs), finished dosage forms such as tablets and capsules, and over-the-counter (OTC) preparations. Towa Pharmaceutical serves both prescription and consumer healthcare markets, offering formulations that address chronic conditions, lifestyle-related illnesses and general wellness.

In addition to its in-house product lines, Towa Pharmaceutical provides contract manufacturing and development services to domestic and international partners.